CN1397554A - 新颖的n－苄基哌嗪化合物、它们的制备方法和含有它们的药物组合物 - Google Patents

新颖的n－苄基哌嗪化合物、它们的制备方法和含有它们的药物组合物 Download PDF

Info

Publication number
CN1397554A
CN1397554A CN02124182A CN02124182A CN1397554A CN 1397554 A CN1397554 A CN 1397554A CN 02124182 A CN02124182 A CN 02124182A CN 02124182 A CN02124182 A CN 02124182A CN 1397554 A CN1397554 A CN 1397554A
Authority
CN
China
Prior art keywords
formula
methyl
piperazinyl
compound
dimethoxyphenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN02124182A
Other languages
English (en)
Chinese (zh)
Inventor
S·拉比达勒
J－P·蒂耶芒
B·特斯塔
R·切凯利
A·勒里丹
C·阿尔佩
M·斯佩丁
E·申克尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Publication of CN1397554A publication Critical patent/CN1397554A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CN02124182A 2001-07-16 2002-07-16 新颖的n－苄基哌嗪化合物、它们的制备方法和含有它们的药物组合物 Pending CN1397554A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0109454 2001-07-16
FR0109454A FR2827284B1 (fr) 2001-07-16 2001-07-16 Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
CN1397554A true CN1397554A (zh) 2003-02-19

Family

ID=8865549

Family Applications (1)

Application Number Title Priority Date Filing Date
CN02124182A Pending CN1397554A (zh) 2001-07-16 2002-07-16 新颖的n－苄基哌嗪化合物、它们的制备方法和含有它们的药物组合物

Country Status (23)

Country Link
US (1) US6686360B2 (https=)
EP (1) EP1277746B1 (https=)
JP (1) JP2003096057A (https=)
KR (1) KR100498867B1 (https=)
CN (1) CN1397554A (https=)
AR (1) AR034779A1 (https=)
AT (1) ATE295358T1 (https=)
AU (1) AU2002300150B2 (https=)
BR (1) BR0202686A (https=)
CA (1) CA2394010A1 (https=)
DE (1) DE60204083T2 (https=)
DK (1) DK1277746T3 (https=)
EA (1) EA005165B1 (https=)
ES (1) ES2241973T3 (https=)
FR (1) FR2827284B1 (https=)
HU (1) HUP0202293A3 (https=)
MX (1) MXPA02006900A (https=)
NO (1) NO20023409L (https=)
NZ (1) NZ520173A (https=)
PL (1) PL355066A1 (https=)
PT (1) PT1277746E (https=)
SI (1) SI1277746T1 (https=)
ZA (1) ZA200205666B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8174436B2 (en) 2002-07-08 2012-05-08 American Underwater Products, Inc. Dive computer with global positioning system receiver
US9443039B2 (en) 2002-07-08 2016-09-13 Pelagic Pressure Systems Corp. Systems and methods for dive computers with remote upload capabilities
WO2004101529A1 (ja) * 2003-05-19 2004-11-25 Ono Pharmaceutical Co., Ltd. 含窒素複素環化合物およびその医薬用途
FR2883876B1 (fr) * 2005-03-30 2007-05-04 Servier Lab Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7797124B2 (en) 2006-12-28 2010-09-14 American Underwater Products, Inc. Dive computer with free dive mode and wireless data transmission
US9821893B2 (en) 2014-10-06 2017-11-21 Pelagic Pressure Systems Corp. System and methods for configurable dive masks with multiple interfaces

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2661176B1 (fr) * 1990-04-20 1992-06-12 Adir Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive.
JPH04356473A (ja) * 1991-05-31 1992-12-10 Wako Pure Chem Ind Ltd ベンジルピペラジン誘導体の新規製造法
FR2681324B1 (fr) * 1991-09-18 1993-10-29 Adir Cie Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2703048B1 (fr) * 1993-03-24 1996-01-05 Adir Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2757164B1 (fr) * 1996-12-16 1999-01-22 Adir Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6479495B1 (en) * 1997-09-29 2002-11-12 Aventis Pharmaceuticals Inc. Aminoalkylphenol derivatives and related compounds

Also Published As

Publication number Publication date
FR2827284A1 (fr) 2003-01-17
NO20023409D0 (no) 2002-07-15
HUP0202293A2 (hu) 2003-04-28
EP1277746A3 (fr) 2003-08-13
EA005165B1 (ru) 2004-12-30
FR2827284B1 (fr) 2003-10-31
US6686360B2 (en) 2004-02-03
HU0202293D0 (https=) 2002-09-28
EP1277746B1 (fr) 2005-05-11
BR0202686A (pt) 2003-05-06
ZA200205666B (en) 2003-03-27
EP1277746A2 (fr) 2003-01-22
KR20030007187A (ko) 2003-01-23
HUP0202293A3 (en) 2004-04-28
DE60204083T2 (de) 2006-03-16
US20030158207A1 (en) 2003-08-21
AR034779A1 (es) 2004-03-17
SI1277746T1 (https=) 2005-08-31
ES2241973T3 (es) 2005-11-01
JP2003096057A (ja) 2003-04-03
MXPA02006900A (es) 2010-11-17
ATE295358T1 (de) 2005-05-15
AU2002300150B2 (en) 2007-10-11
NO20023409L (no) 2003-01-17
CA2394010A1 (fr) 2003-01-16
EA200200682A1 (ru) 2003-02-27
DK1277746T3 (da) 2005-08-29
PT1277746E (pt) 2005-07-29
PL355066A1 (en) 2003-01-27
NZ520173A (en) 2004-02-27
DE60204083D1 (de) 2005-06-16
KR100498867B1 (ko) 2005-07-04

Similar Documents

Publication Publication Date Title
CN1040761C (zh) 含乙基膦酸酯侧链的稠合含氮杂环衍生物含有它们的药物组合物及其应用
CN1310907C (zh) 杂环化合物和以其为有效成分的抗肿瘤药
CN1235890C (zh) 噻唑基酰胺衍生物
CN1043639C (zh) 新的哌啶化合物、其制备方法和含有它们的药用组合物
CN1027068C (zh) α-取代的4-(喹啉-2-基-甲氧基)苯乙酸和酯的制备方法
CN1516699A (zh) 1-[4-(5-氰基吲哚-3-基)丁基]-4-(2-氨甲酰-苯并呋喃-5-基)-哌嗪盐酸盐的多晶型物
CN1551881A (zh) 新颖二氢喋啶酮,其制备方法及作为药物组合物的用途
CN1699343A (zh) 盐酸多奈哌齐的多晶型物及其制备方法
CN1539828A (zh) 含氮杂环羧酰胺衍生物或其盐
CN1183156C (zh) 杂环化合物、其中间体和弹性蛋白酶抑制剂
CN1182127C (zh) 新的取代的2-苯并[c]呋喃酮化合物,其制备方法以及包含它们的药物组合物
CN1103534A (zh) 具有抗精神病作用的化合物
CN1174984C (zh) 氨基甲酰基四氢吡啶衍生物
CN1058494C (zh) 新的洋芫荽黄素化合物，其制备方法和含它们的药用组合物
CN1795179A (zh) 新的咪唑衍生物、其制备方法和其作为药物的用途
CN1397554A (zh) 新颖的n－苄基哌嗪化合物、它们的制备方法和含有它们的药物组合物
CN1535149A (zh) 噻唑基酰胺类化合物的局部应用
CN1662519A (zh) 新化合物及其作为甘氨酸转运抑制剂的用途
CN1147494C (zh) 新型苯并噻二嗪化合物,其制备方法及含它们的药物组合物
CN1177354A (zh) 嘧啶并[4,5－b]吲哚
CN1418196A (zh) 用于抗充血性心力衰竭的哒嗪基苯基腙
CN1256336C (zh) 新的4′－脱甲基－4′－o－取代的－1－脱氧鬼臼毒衍生物及其几何异构体,制备方法和包含它的抗癌组合物
CN1130183A (zh) 1,4-苯并噁嗪衍生物，含该化合物的药物组合物及其用途
CN1079742A (zh) 制备嘧啶衍生物及其医药上可用的盐的方法
CN1296356C (zh) Ccr－3受体拮抗剂vii

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1052177

Country of ref document: HK